Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose transporter proteins are a broad group of membrane proteins that facilitate the movement of glucose across cellular plasma membranes via facilitated diffusion. This process is essential because glucose, a primary energy source for most living organisms, cannot freely cross the lipid bilayer. There are two main types: Facilitated diffusion glucose transporters (GLUTs/SLC2A family) and Sodium–glucose linked transporters (SGLTs). The human genome encodes 14 GLUT isoforms (GLUT1–14), each with distinct tissue distributions and substrate specificities. GLUTs operate via an "alternate conformation" model. Glucose transporter dysfunction can lead to metabolic diseases such as diabetes mellitus. SGLT inhibitors are used therapeutically for diabetes management.
Facilitated diffusion of glucose across the cell membrane; Sodium-dependent glucose co-transport.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose Transporter Protein (GLUT).